We hypothesized that early-stage CIN in cancer cells can stimulate anti-cancer activity of macrophages sufficient to dominate proliferation of high CIN tumors, but probably only when maximizing pro-phagocytic conditions, such as with blockade of SIRPα (rather than ubiquitous CD47). The gene discussed is CD47; the disease is cancer.